Position in LXRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$24,000
+$8,400 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#118
of 148 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NBT BANK N A /NY holds $150,148 across 14 Biotechnology names. LXRX ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157 | $97,895 | |
| 2 | LXRX |
Lexicon Pharmaceuticals, Inc.
This page
|
10,000 | $24,000 | |
| 3 | ANIX |
Anixa Biosciences Inc
|
2,000 | $5,600 | |
| 4 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6 | $2,980 | |
| 6 | MRNA |
Moderna, Inc.
|
40 | $2,801 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
13 | $2,434 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
25 | $1,956 |
All Filings in LXRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,000 | 10,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $15,600 | 10,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $11,500 | 10,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $13,500 | 10,000 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $9,500 | 10,000 | Shares | Sole | 2025-07-23 | |
| No filing history on record for this holder in this stock. | ||||||